Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

12
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
12
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

494
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
494
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

223
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
223
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

9
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
9

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating Patient Preferences for Clinical Trial Endpoints in Early-Stage Cancer: A Discrete Choice Experiment in Canada.

Current oncology (Toronto, Ont.)·2026
Same author

The diagnosis and management of portal hypertension in cirrhosis: The Gastroenterological Society of Australia consensus.

Hepatology communications·2026
Same author

The Development of Canonical Proportion as a Function of Community, Multilingualism, and Target Language's Syllable Complexity.

Journal of child language·2026
Same author

A Comparison of an Intensive Short-Term Dynamic Group Therapy to a Dialectical Behavior Therapy Skills Group Program for People with Personality Vulnerabilities: A Randomized Pilot Study for Feasibility.

Psychodynamic psychiatry·2025
Same author

Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial.

JCI insight·2025
Same author

Development and implementation of a digital health intervention in routine care for long COVID patients: a comprehensive synopsis.

Health and social care delivery research·2025
Same journal

Dual antihypertensive fixed-dose combinations approved for first-line use on the Pharmaceutical Benefits Scheme.

Australian prescriber·2026
Same journal

Capivasertib for locally advanced or metastatic breast cancer.

Australian prescriber·2026
Same journal

Diagnosis and management of irritable bowel syndrome.

Australian prescriber·2026
Same journal

Stopping antidepressants: when and how.

Australian prescriber·2026
Same journal

Emergency contraception: an overview.

Australian prescriber·2026
Same journal

Sodium valproate: balancing benefits and risks especially in people of childbearing potential.

Australian prescriber·2026
See all related articles

Related Experiment Video

Updated: Oct 7, 2025

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

21.4K

Testing for cirrhosis.

Sidhartha Gupta1, Sarah Walker1

  • 1Canberra Hospital and Health Services, Canberra.

Australian Prescriber
|January 10, 2022
PubMed
Summary
This summary is machine-generated.

Diagnosing cirrhosis, a serious liver condition, relies on clinical assessment and specific tests. Non-invasive methods like serum biomarkers and imaging significantly aid in early detection and management, improving patient outcomes.

Keywords:
cirrhosisliver biopsyliver function

More Related Videos

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

11.5K
The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat
09:27

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat

Published on: June 17, 2016

12.2K

Related Experiment Videos

Last Updated: Oct 7, 2025

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

21.4K
Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

11.5K
The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat
09:27

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat

Published on: June 17, 2016

12.2K

Area of Science:

  • Hepatology and Gastroenterology
  • Diagnostic Medicine
  • Biomarker Discovery

Background:

  • Compensated liver disease, often asymptomatic, necessitates reliable diagnostic tools for cirrhosis identification.
  • Clinical assessment alone is insufficient for diagnosing advanced liver disease and cirrhosis.

Purpose of the Study:

  • To highlight critical investigations for identifying patients with advanced liver disease and cirrhosis.
  • To emphasize the role of biomarkers and non-invasive imaging in cirrhosis assessment and management.

Main Methods:

  • Utilizing biomarkers and validated serum tests to evaluate liver damage and synthetic function.
  • Employing the aspartate aminotransferase to platelet count ratio (APRI) for cirrhosis prediction.
  • Implementing non-invasive imaging techniques, including ultrasound and elastography, as adjuncts to clinical assessment.

Main Results:

  • Serum tests and biomarkers effectively assess liver damage and function.
  • The aspartate aminotransferase to platelet count ratio demonstrates predictive value for cirrhosis.
  • Non-invasive imaging reduces the reliance on liver biopsy for cirrhosis diagnosis.

Conclusions:

  • Early diagnosis of cirrhosis through a combination of clinical assessment, biomarkers, and non-invasive imaging is crucial.
  • Careful monitoring, appropriate prescribing, and specialist referral are key components of cirrhosis management.
  • Improved diagnostic strategies can lead to better patient outcomes in cirrhosis.